ZNF217 and bone metastasis: used RT-qPCR to detect ZNF217 mRNA expression in 113 breast cancer samples and found that high expression of ZNF217 is associated with a higher risk of isolated bone metastasis in ER+ patients, but the level of ZNF217 cannot predict metastasis in other subtypes of breast cancer [112].